Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Parkinson disease and the gut: new insights into pathogenesis and clinical relevance
R. Alberto Travagli, Kirsteen N. Browning, Michael Camilleri
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 11, pp. 673-685
Closed Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Role of Microbiota-Gut-Brain Axis in Regulating Dopaminergic Signaling
Sevag Hamamah, Armin Aghazarian, Anthony Nazaryan, et al.
Biomedicines (2022) Vol. 10, Iss. 2, pp. 436-436
Open Access | Times Cited: 155
The enteric nervous system
Keith A. Sharkey, Gary M. Mawe
Physiological Reviews (2022) Vol. 103, Iss. 2, pp. 1487-1564
Closed Access | Times Cited: 145
Gastrointestinal motility disorders in neurologic disease
Michael Camilleri
Journal of Clinical Investigation (2021) Vol. 131, Iss. 4
Open Access | Times Cited: 122
Effects of dietary intervention on human diseases: molecular mechanisms and therapeutic potential
Yu-Ling Xiao, Yue Gong, Ying-Jia Qi, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 65
Gut microbiome-targeted therapies for Alzheimer’s disease
Tao Zhang, Guangqi Gao, Lai‐Yu Kwok, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 42
Helicobacter pylori infection and Parkinson’s Disease: etiology, pathogenesis and levodopa bioavailability
Bang-rong Wei, Yujia Zhao, Yufeng Cheng, et al.
Immunity & Ageing (2024) Vol. 21, Iss. 1
Open Access | Times Cited: 16
Bridging gap in the treatment of Alzheimer’s disease via postbiotics: Current practices and future prospects
Bushra Bashir, Monica Gulati, Sukriti Vishwas, et al.
Ageing Research Reviews (2025), pp. 102689-102689
Closed Access | Times Cited: 2
The Role of Intestinal Macrophages in Gastrointestinal Homeostasis: Heterogeneity and Implications in Disease
Jackson L. K. Yip, Gayathri K. Balasuriya, Sarah J. Spencer, et al.
Cellular and Molecular Gastroenterology and Hepatology (2021) Vol. 12, Iss. 5, pp. 1701-1718
Open Access | Times Cited: 88
Curcumin nanoformulations to combat aging-related diseases
Maryam Mahjoob, Ursula Stochaj
Ageing Research Reviews (2021) Vol. 69, pp. 101364-101364
Closed Access | Times Cited: 69
Neuroprotective effects of short-chain fatty acids in MPTP induced mice model of Parkinson's disease
Yichao Hou, Xingqi Li, Chang Liu, et al.
Experimental Gerontology (2021) Vol. 150, pp. 111376-111376
Closed Access | Times Cited: 68
Anti-Parkinsonian Therapy: Strategies for Crossing the Blood–Brain Barrier and Nano-Biological Effects of Nanomaterials
Guowang Cheng, Yujing Liu, Rui Ma, et al.
Nano-Micro Letters (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 64
Vagus Nerve and Stomach Synucleinopathy in Parkinson’s Disease, Incidental Lewy Body Disease, and Normal Elderly Subjects: Evidence Against the “Body-First” Hypothesis
Thomas G. Beach, Charles H. Adler, Lucia I. Sue, et al.
Journal of Parkinson s Disease (2021) Vol. 11, Iss. 4, pp. 1833-1843
Open Access | Times Cited: 62
Gut–Brain Axis as a Pathological and Therapeutic Target for Neurodegenerative Disorders
Alma Rosa Lezama Toledo, Germán Rivera Monroy, Félipe Esparza Salazar, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 3, pp. 1184-1184
Open Access | Times Cited: 61
Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis
Júlio César Claudino dos Santos, Micael Porto Portela Lima, Gerly Anne de Castro Brito, et al.
Ageing Research Reviews (2022) Vol. 84, pp. 101812-101812
Closed Access | Times Cited: 54
Propagation of tau and α-synuclein in the brain: therapeutic potential of the glymphatic system
Douglas M. Lopes, Sophie K. Llewellyn, Ian F. Harrison
Translational Neurodegeneration (2022) Vol. 11, Iss. 1
Open Access | Times Cited: 43
Physical Frailty, Genetic Predisposition, and Incident Parkinson Disease
Zekun Zheng, Yanling Lv, Shuang Rong, et al.
JAMA Neurology (2023) Vol. 80, Iss. 5, pp. 455-455
Open Access | Times Cited: 37
Lactobacillus plantarum CCFM405 against Rotenone-Induced Parkinson’s Disease Mice via Regulating Gut Microbiota and Branched-Chain Amino Acids Biosynthesis
Chuanqi Chu, Leilei Yu, Yiwen Li, et al.
Nutrients (2023) Vol. 15, Iss. 7, pp. 1737-1737
Open Access | Times Cited: 34
Gastrointestinal syndromes preceding a diagnosis of Parkinson’s disease: testing Braak’s hypothesis using a nationwide database for comparison with Alzheimer’s disease and cerebrovascular diseases
Bo Konings, Luisa Villatoro, Jef Van den Eynde, et al.
Gut (2023) Vol. 72, Iss. 11, pp. 2103-2111
Open Access | Times Cited: 29
Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
Yi Zhang, Shaoqing Xu, Yiwei Qian, et al.
Frontiers in Aging Neuroscience (2023) Vol. 15
Open Access | Times Cited: 26
Gut-induced alpha-Synuclein and Tau propagation initiate Parkinson’s and Alzheimer’s disease co-pathology and behavior impairments
Jie Xiang, Jingrong Tang, Fei Kang, et al.
Neuron (2024)
Closed Access | Times Cited: 12
An ingestible device for gastric electrophysiology
Siheng Sean You, Adam Gierlach, Paul G. Schmidt, et al.
Nature Electronics (2024) Vol. 7, Iss. 6, pp. 497-508
Closed Access | Times Cited: 10
Contribution of Nutritional, Lifestyle, and Metabolic Risk Factors to Parkinson's Disease
Nicola Veronese, Andrea Nova, Teresa Fazia, et al.
Movement Disorders (2024) Vol. 39, Iss. 7, pp. 1203-1212
Closed Access | Times Cited: 8
Activation of α7nAch receptors ameliorates α-synuclein pathology in the brain and gut of a subacute MPTP mouse model of Parkinson's disease
Yea‐Hyun Leem, Jung‐Eun Park, Jin‐Sun Park, et al.
Biomedicine & Pharmacotherapy (2025) Vol. 184, pp. 117871-117871
Open Access | Times Cited: 1
Gender Differences and Quality of Life in Parkinson’s Disease
Pietro Crispino, Miriam Gino, Elena Barbagelata, et al.
International Journal of Environmental Research and Public Health (2020) Vol. 18, Iss. 1, pp. 198-198
Open Access | Times Cited: 60
Treating LRRK2‐Related Parkinson's Disease by Inhibiting the mTOR Signaling Pathway to Restore Autophagy
Weitong Cui, Xiao Yang, Xingyu Chen, et al.
Advanced Functional Materials (2021) Vol. 31, Iss. 38
Closed Access | Times Cited: 49
Page 1 - Next Page

Scroll to top